Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea

Clinical trial NCT02156895 · COMPLETED

Trial details

NCT number: NCT02156895
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Advanced Renal Cell Carcinoma

Start date: 2018-07-17
Primary completion: 2021-04-21
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.